R&D
Next Pipeline
An ultra-compact wearable medical device redefining
traditional large, wired medical equipment.
Technology
Convenience
Sleep apnea
monitoring device
Blood pressure
monitoring device
Wearable medical
device for animals
Invasive glucose
monitoring device
Traditional
ECG Holter
Equipment

Traditional hospital-based
equipment—limited
convenience and high cost.

Sleep apnea
monitoring device
Continuous blood pressure
monitoring device
(under development)
Wearable medical
device for animals
Non-invasive Glucose Monitoring
Device (Under Development)
Wearable
ECG device
Ultra-compact,
high-sensitivity
wearable device

House hold
Daily Life
Low Cost

Patents
Total patents 44
  • 7

    ECG sensing performance
    supported by evidence

  • 17

    Up to 14-day continuous
    monitoring and ECG
    data review

  • 6

    Designed for daily life:
    lightweight, wireless,
    and daily-use oriented

  • 10

    Physiological signal
    monitoring and
    data management

AI Algorithm

Proprietary AI algorithms protected by multiple domestic and international patents.
Technology developed to support ECG data review, with regulatory status and clinical evidence varying by market.

Certification

Regulatory Status Across Key Markets.
Availability varies by country and model.

Korea

MFDS

UK

MHRA

USA

FDA

Japan

PMDA

Europe

CE MDR

Korea

MFDS

UK

MHRA

USA

FDA

Japan

PMDA

Europe

CE MDR

North America
  • USA
  • Canada
South America
  • Brazil
  • Peru
  • Colombia
  • Dominican Republic
  • Ecuador
  • Argentina
Europe
  • Germany
  • Greece
  • Hungary
  • Romania
  • Bosnia & Herzegovina
  • Serbia & Montenegro
  • Spain, Poland
  • Italy, The U.K.
  • Belarus
Asia
  • Hong Kong, Macau
  • Sri Lanka, Maldives
  • Mongolia, India
  • Turkey, Indonesia
  • Malaysia
  • Thailand
  • Singapore
  • Vietnam
  • Brunei
Middle East
  • Cyprus
  • KSA
  • Kuwait
  • Qatar
  • UAE
  • Oman, Bahrain
  • Jordan
  • Iraq
  • Israel
CIS
  • Russia
  • Azerbaijan
Oceania
  • New Zealand
Africa
  • Mauritius
  • South Africa
  • Senegal, Libya
  • Algeria
  • Morocco
SCIENTIFIC VALIDATION Clinical Research & Evidence
The First Everest ECG Explorer

Tough enough for extreme conditions. Published in JAMA Cardiology.

  • Research Partner Bern University Hospital

    Switzerland (Inselspital)

  • Participants 30 Healthy Adults

    Rigorous selection process

  • Performance Max 14 Days Continuous

    Uninterrupted ECG monitoring

ATsens
Publications